关注
Sushanth Gouni
Sushanth Gouni
在 mdanderson.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome
SW Canna, AA de Jesus, S Gouni, SR Brooks, B Marrero, Y Liu, ...
Nature genetics 46 (10), 1140-1146, 2014
7782014
A multicenter retrospective study of polatuzumab vedotin in patients with large B-cell lymphoma after CAR T-cell therapy
S Gouni, AC Rosenthal, JL Crombie, A Ip, MK Kamdar, B Hess, L Feng, ...
Blood Advances 6 (9), 2757-2762, 2022
342022
PortEco: a resource for exploring bacterial biology through high-throughput data and analysis tools
JC Hu, G Sherlock, DA Siegele, SA Aleksander, CA Ball, J Demeter, ...
Nucleic acids research 42 (D1), D677-D684, 2014
272014
Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response
AP Jallouk, S Gouni, J Westin, L Feng, H Mistry, RE Steiner, J James, ...
Haematologica 108 (4), 1163, 2022
122022
Statins enhance the chemosensitivity of R-CHOP in diffuse large B-cell lymphoma
S Gouni, P Strati, G Toruner, A Aradhya, R Landgraf, D Bilbao, F Vega, ...
Leukemia & lymphoma 63 (6), 1302-1313, 2022
122022
Follicular lymphoma and macrophages: impact of approved and novel therapies
S Gouni, ML Marques-Piubelli, P Strati
Blood Advances 5 (20), 4303-4312, 2021
122021
NLRC4 gets out of control
HJ Khameneh, A Mortellaro
Nature Genetics 46 (10), 1048-1049, 2014
82014
SIRPα+ macrophages are increased in patients with FL who progress or relapse after frontline lenalidomide and rituximab
ML Marques-Piubelli, ER Parra, L Feng, LS Soto, M Gallardo, S Gouni, ...
Blood Advances 6 (11), 3286-3293, 2022
62022
A157: Macrophage Activation Syndrome‐like Illness Due to an Activating Mutation in NLRC4
S Canna, AA de Jesus, Z Deng, S Gouni, B Marrero, S Brooks, M Dimattia, ...
Arthritis & Rheumatology 66, S203-S203, 2014
52014
Bispecific antibody use in patients with lymphoma and multiple myeloma
A Braun, S Gouni, A Pulles, P Strati, MC Minnema, LE Budde
American Society of Clinical Oncology Educational Book 44 (3), e433516, 2024
42024
A multi-center retrospective study of polatuzumab for patients with large B-cell lymphoma relapsed after standard of care CAR T-cell therapy
S Gouni, AC Rosenthal, JL Crombie, A Ip, M Kamdar, BT Hess, L Feng, ...
Blood 138, 2495, 2021
32021
Rate of progression of aortic stenosis in patients with cancer
K Bravo-Jaimes, NL Palaskas, J Banchs, NI Abelhad, A Altaf, S Gouni, ...
Frontiers in Cardiovascular Medicine 8, 644264, 2021
32021
A Phase II Investigator Initiated Study of Acalabrutinib, Lenalidomide and Rituximab (aR2) in Patients with Previously Untreated High Tumor Burden Follicular Lymphoma.
P Strati, L Feng, J Westin, R Nair, S Gouni, L Fayad, M Rodriguez, ...
Hematological Oncology 41, 2023
22023
BCL-W expression associates with poor outcome in patients with peripheral T-cell lymphoma not otherwise specified
ML Marques-Piubelli, LM Solis, ER Parra, LM Castillo, S Gouni, R Nair, ...
Blood cancer journal 11 (9), 153, 2021
22021
Recommended articles
CMS Silva, G Habermann, G Loebenstein, N Katis, MC de Souza, ...
Flora 235, 51-58, 2017
12017
Impact of Pre-Treatment Liver-Related Factors on Clinical Outcomes after CAR T-Cell Therapy for Lymphoma
A Lionel, S Gouni, L Feng, C Gaulin, AS Gonugunta, T Saridogan, ...
Blood 144, 4506, 2024
2024
Peripheral Blood CAR T-Cell Level Using a Clia-Validated Assay Is Prognostic for Treatment Response and Icans in Large B-Cell Lymphoma
A Lionel, N Kui, R Sun, E Aboismail, SO Tewari, A Al Zaki, S Gouni, P Jain, ...
Blood 144, 3001, 2024
2024
Impact of Pre-Existing Mental Health Disorders (MHD) on CAR T-Cell Therapy Outcomes in Patients with Large B-Cell Lymphoma
S Gouni, A Lionel, L Feng, C Gaulin, T Reddy, AS Gonugunta, V Chu, ...
Blood 144, 4508, 2024
2024
P1092: A PHASE II INVESTIGATOR INITIATED STUDY OF ACALABRUTINIB, LENALIDOMIDE AND RITUXIMAB (AR2) IN PATIENTS WITH PREVIOUSLY UNTREATED HIGH TUMOR BURDEN FOLLICULAR LYMPHOMA
P Strati, L Feng, J Westin, R Nair, S Gouni, L Fayad, M Rodriguez, ...
HemaSphere 7 (S3), e6330214, 2023
2023
An Updated Multi-Center Retrospective Study of Polatuzumab for Patients with Large B-Cell Lymphoma Relapsed after Standard of Care CAR T-Cell Therapy
P Strati, A Rosenthal, S Gouni, JL Crombie, A Ip, M Kamdar, B Hess, ...
2022 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2022
2022
系统目前无法执行此操作,请稍后再试。
文章 1–20